By Kate Frisher, Campaigns Coordinator
We’re excited to announce our second free webinar of 2018!
On Wednesday, February 7 at 1pm ET / 10am PT join us to learn about the alarming and controversial drug access legislation known as “Right to Try.” This webinar will break down the history of Right to Try legislation and help make sense of what the passage of federal legislation could mean for patient safety, the Food and Drug Administration (FDA)’s authority to regulate drugs in development, and how it all affects you. Last but not least, we’ll provide opportunities for how and where you can add your voice to make a difference.
At first glance, the phrase “Right to Try” sounds great for patients—breaking down “barriers” terminally ill, including metastatic breast cancer, patients encounter when accessing experimental treatments via clinical trials. But the truth is patients can already access experimental drugs quickly through existing FDA programs.
Right to Try is misleading and suggests there’s a problem where one doesn’t exist. It does nothing more than allow patients to bypass the FDA to access potentially dangerous or useless treatments outside of the framework and medical oversight of existing programs. Right to Try is really “False Hope”—promising more than what it will give and potentially making it more difficult for proven new drugs to actually get to market for all.
Register for Wednesday, February 7 at 1pm ET / 10am PT
Our featured speaker is Alison Bateman-House, MPH, PhD, a medical ethicist with New York University’s School of Medicine. She is a public health expert with vast knowledge on bioethics, the FDA’s compassionate use program, and clinical trials. Dr. Bateman-House is a leader in her field. She, along with other medical experts and patient advocates, has been a vocal critic of Right to Try legislation. Join us to learn more about why patients need treatments that work, not a free for all that undermines public health and medical progress.
Register today for a free webinar about Right to Try on Wednesday, February 7th at 1pm ET / 10am PT. We’ll have time for Q&A, so bring your questions!
Can’t make it? Register anyway and you’ll automatically receive a link to a recording of the webinar so you can tune in whenever is convenient for you.